An artificial intelligence (AI)-based platform, developed in a multi-institutional collaborative research, enhanced the evaluations of providers regarding whether bladder cancer patients had a total response to chemotherapy treatment prior to a radical cystectomy (bladder removal surgery).
Artificial intelligence helps physicians better assess effectiveness of bladder cancer treatment miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Investegate announcements from Ultimovacs ASA, Ultimovacs ASCO Phase I data shows 60% ORR in advanced melanoma with UV1/pembrolizumab, supporting broad Phase II combination program
UV1/pembrolizumab results in 30% complete responses plus 30% partial responsesGood safety and tolerability profile supports expanded Phase II combination programData highlighted at ASCO in poster presentation